For example, the mGlu4 positive allosteric modulator, PHCCC, and the mGlu7 allosteric agonist AMN082 provided relief from akinesia in a reserpine-treated rat model of Parkinson’s disease, which the authors believed most likely reflected the inhibition of excess glutamate release [34]. Here, GRM4 is linked to Parkinson disease.